Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01EJ01	CELEZON	G	Ruxolitinib - 5mg	5mg	Tablet	L.L
L01EJ01	CELEZON	G	Ruxolitinib - 15mg	15mg	Tablet	L.L
L01EJ01	CELEZON	G	Ruxolitinib - 20mg	20mg	Tablet	L.L
L01EL02	CALQUENCE	B	Acalabrutinib - 100mg	100mg	Tablet, film coated	650,653,454 L.L
L01EX07	CABOMETYX	B	Cabozantinib - 20mg	20mg	Tablet, film coated	440,893,501 L.L
L01EX07	CABOMETYX	B	Cabozantinib - 40mg	40mg	Tablet, film coated	440,893,501 L.L
L01EX07	CABOMETYX	B	Cabozantinib - 60mg	60mg	Tablet, film coated	440,893,501 L.L
L01FG02	CYRAMZA	BioTech	Ramucirumab - 500mg/50ml	500mg/50ml	Injectable solution	L.L
L01FG02	CYRAMZA	BioTech	Ramucirumab - 100mg/10ml	100mg/10ml	Injectable solution	47,779,251 L.L
L01FG02	CYRAMZA	BioTech	Ramucirumab - 500mg/50ml	500mg/50ml	Injectable solution	218,656,548 L.L
L01FX28	COLUMVI	BioTech	Glofitamab - 10mg/10ml	10mg/10ml	Injectable concentrate for solution	349,443,660 L.L
L01FX28	COLUMVI	BioTech	Glofitamab - 2.5mg/2.5ml	2.5mg/2.5ml	Injectable concentrate for solution	87,389,307 L.L
L01XA01	CISPLATINE VIATRIS 1MG/ML	G	Cisplatin - 10mg/10ml	10mg/10ml	Injectable concentrated solution	412,655 L.L
L01XA01	CIPINTU	G	Cisplatin - 50mg/50ml	50mg/50ml	Injectable concentrated solution	1,206,771 L.L
L01XA01	CISPLATINE VIATRIS 1MG/ML	G	Cisplatin - 50mg/50ml	50mg/50ml	Injectable concentrated solution	1,179,655 L.L
L01XA02	CARBOPLATIN VIANEX	G	Carboplatin - 150mg/15ml	150mg/15ml	Injectable solution	1,277,994 L.L
L01XA02	CARBOPLATINE EBEWE	G	Carboplatin - 150mg/15ml	150mg/15ml	Injectable concentrated solution	2,691,717 L.L
L01XA02	CARBOPLATINE VIATRIS 10MG/ML	G	Carboplatin - 150mg/15ml	150mg/15ml	Injectable solution	2,981,283 L.L
L01XA02	CARPLATU	G	Carboplatin - 150mg/15ml	150mg/15ml	Injectable solution	1,277,994 L.L
L01XA02	CARBOPLATINE VIATRIS 10MG/ML	G	Carboplatin - 50mg/5ml	50mg/5ml	Injectable solution	941,930 L.L
L01XX05	CUREAML	G	Hydroxycarbamide (or Hydroxyurea) - 500mg	500mg	Capsule	1,228,272 L.L
L01XX05	CYTODROX	G	Hydroxycarbamide (or Hydroxyurea) - 500mg	500mg	Capsule	3,301,821 L.L
L02BB03	CASODEX	B	Bicalutamide - 50mg	50mg	Tablet, film coated	3,777,541 L.L
L02BB03	CASODEX	B	Bicalutamide - 150mg	150mg	Tablet, film coated	10,863,782 L.L
L03AB07	CINNOVEX	BioTech	Interferon beta-1a - 30mcg	30mcg	Injectable solution	39,804,728 L.L
L04AA06	CELLCEPT	B	Mycophenolate mofetil - 250mg	250mg	Capsule	6,083,575 L.L
L04AA06	CELLCEPT	B	Mycophenolate mofetil - 500mg	500mg	Tablet	6,083,575 L.L
L04AA18	CERTICAN	B	Everolimus - 0.5mg	0.5mg	Tablet	26,832,962 L.L
L04AA18	CERTICAN	B	Everolimus - 0.75mg	0.75mg	Tablet	26,832,962 L.L
L04AA18	CERTICAN	B	Everolimus - 0.5mg	0.5mg	Tablet	L.L

...